You can buy or sell TBPH and other stocks, options, ETFs, and crypto commission-free!
Theravance Biopharma, Inc. operates as a biopharmaceutical company. It focuses on the discovery, research, development, and commercialization of small molecule medicines. Read More Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.
George Town, George Town
52 Week High
52 Week Low
North America (Non-US/Canada)
Seeking AlphaMay 7
Theravance Biopharma, Inc. (TBPH) CEO Rick Winningham on Q1 2019 Results - Earnings Call Transcript
Theravance Biopharma, Inc. (NASDAQ:TBPH) Q1 2019 Earnings Conference Call May 7, 2019 5:00 PM ET Company Participants Jessica Stitt - Vice President, Finance & Investor Relations Rick Winningham - Chief Executive Officer Brett Haumann - Chief Medical Officer Frank Pasqualone - Senior Vice President & Chief Commercial Operations Officer Conference Call Participants Brad Canino - SVB Leerink Louise Chen - Cantor Fitzgerald Alex Duncan - Piper Jaffray Brian Skorney - Baird Alan Carr - Needham Opera...
Expected Jul 31, After Hours